{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:42Z","timestamp":1707524682130},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,22]]},"DOI":"10.7759\/cureus.26213","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T23:22:21Z","timestamp":1655940141000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Refractory Anemia in a Patient With Glycogen Storage Disease Type Ia Undergoing Hemodialysis"],"prefix":"10.7759","author":[{"given":"Hirotaka","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Takase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seikon","family":"Kin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e3282fcbc0f","article-title":"Inherited metabolic disease of the liver","volume":"24","author":"Taddei T","year":"2008","unstructured":"Taddei T, Mistry P, Schilsky ML. Inherited metabolic disease of the liver. Curr Opin Gastroenterol. 2008, 24:278-86. 10.1097\/MOG.0b013e3282fcbc0f","journal-title":"Curr Opin Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113828","article-title":"Glycogen storage disease type Ia: current management options, burden and unmet needs","volume":"13","author":"Derks TG","year":"2021","unstructured":"Derks TG, Rodriguez-Buritica DF, Ahmad A, et al.. Glycogen storage disease type Ia: current management options, burden and unmet needs. Nutrients. 2021, 13:10.3390\/nu13113828","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/S00431-002-0999-4","article-title":"Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Rake J","year":"2002","unstructured":"Rake J, Visser G, Labrune P, Leonard J, Ullrich K, Smit P. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr. 2002, 161:20-34. 10.1007\/S00431-002-0999-4","journal-title":"Eur J Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani PS","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, et al.. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014, 16:10.1038\/gim.2014.128","journal-title":"Genet Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-3-199402010-00008","article-title":"Glycogen storage disease in adults","volume":"120","author":"Talente GM","year":"1994","unstructured":"Talente GM, Coleman RA, Alter C, et al.. Glycogen storage disease in adults. Ann Intern Med. 1994, 120:218-26. 10.7326\/0003-4819-120-3-199402010-00008","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801073180102","article-title":"Renal disease in type I glycogen storage disease","volume":"318","author":"Chen YT","year":"1988","unstructured":"Chen YT, Coleman RA, Scheinman JI, Kolbeck PC, Sidbury JB. Renal disease in type I glycogen storage disease. N Engl J Med. 1988, 318:7-11. 10.1056\/NEJM198801073180102","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00050109","article-title":"Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition","volume":"4","author":"Martens DH","year":"2009","unstructured":"Martens DH, Rake JP, Navis G, Fidler V, van Dael CM, Smit GP. Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition. Clin J Am Soc Nephrol. 2009, 4:1741-6. 10.2215\/CJN.00050109","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nephro.2014.12.007","article-title":"Renal involvement in glycogen storage disease type 1: practical issues. [Article in French]","volume":"11","author":"Ben Chehida A","year":"2015","unstructured":"Ben Chehida A, Bensma\u00efl T, Ben Rehouma F, et al.. Renal involvement in glycogen storage disease type 1: practical issues. [Article in French]. Nephrol Ther. 2015, 11:240-5. 10.1016\/j.nephro.2014.12.007","journal-title":"Nephrol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.642296","article-title":"Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents","volume":"8","author":"Portol\u00e9s J","year":"2021","unstructured":"Portol\u00e9s J, Mart\u00edn L, Broseta JJ, Cases A. Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents. Front Med (Lausanne). 2021, 8:10.3389\/fmed.2021.642296","journal-title":"Front Med (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/S00431-002-1002-0","article-title":"Glycogen storage disease type I: pathophysiology of liver adenomas","volume":"161","author":"Lee P","year":"2002","unstructured":"Lee P. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr. 2002, 161:46-9. 10.1007\/S00431-002-1002-0","journal-title":"Eur J Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp441","article-title":"Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease","volume":"18","author":"Kishnani PS","year":"2009","unstructured":"Kishnani PS, Chuang TP, Bali D, et al.. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. Hum Mol Genet. 2009, 18:4781-90. 10.1093\/hmg\/ddp441","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.09.030","article-title":"Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I","volume":"58","author":"Calderaro J","year":"2013","unstructured":"Calderaro J, Labrune P, Morcrette G, et al.. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol. 2013, 58:350-7. 10.1016\/j.jhep.2012.09.030","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/HEP.1840180327","article-title":"Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis","volume":"18","author":"Ockner RK","year":"1993","unstructured":"Ockner RK, Kaikaus RM, Bass NM. Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis. Hepatology. 1993, 18:669-76. 10.1002\/HEP.1840180327","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.02.031","article-title":"Natural history of hepatocellular adenoma formation in glycogen storage disease type I","volume":"159","author":"Wang DQ","year":"2011","unstructured":"Wang DQ, Fiske LM, Carreras CT, Weinstein DA. Natural history of hepatocellular adenoma formation in glycogen storage disease type I. J Pediatr. 2011, 159:442-6. 10.1016\/j.jpeds.2011.02.031","journal-title":"J Pediatr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2012.41","article-title":"Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib","volume":"14","author":"Wang DQ","year":"2012","unstructured":"Wang DQ, Carreras CT, Fiske LM, Austin S, Boree D, Kishnani PS, Weinstein DA. Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib. Genet Med. 2012, 14:795-9. 10.1038\/gim.2012.41","journal-title":"Genet Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz T","year":"2012","unstructured":"Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012, 1823:1434-43. 10.1016\/j.bbamcr.2012.01.014","journal-title":"Biochim Biophys Acta"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3945\/an.116.013961","article-title":"Regulation of the iron homeostatic hormone hepcidin","volume":"8","author":"Sangkhae V","year":"2017","unstructured":"Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin. Adv Nutr. 2017, 8:126-36. 10.3945\/an.116.013961","journal-title":"Adv Nutr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1260","article-title":"Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease","volume":"100","author":"Weinstein DA","year":"2002","unstructured":"Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002, 100:3776-81. 10.1182\/blood-2002-04-1260","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/nu10091173","article-title":"Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease","volume":"10","author":"Ueda N","year":"2018","unstructured":"Ueda N, Takasawa K. Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease. Nutrients. 2018, 10:10.3390\/nu10091173","journal-title":"Nutrients"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132006","article-title":"Reassessment of iron biomarkers for prediction of dialysis iron overload: an MRI study","volume":"10","author":"Rostoker G","year":"2015","unstructured":"Rostoker G, Griuncelli M, Loridon C, et al.. Reassessment of iron biomarkers for prediction of dialysis iron overload: an MRI study. PLoS One. 2015, 10:10.1371\/journal.pone.0132006","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/102436-successful-treatment-of-refractory-anemia-in-a-patient-with-glycogen-storage-disease-type-ia-undergoing-hemodialysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:24Z","timestamp":1707507504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/102436-successful-treatment-of-refractory-anemia-in-a-patient-with-glycogen-storage-disease-type-ia-undergoing-hemodialysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.26213","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,22]]}}}